Vaginal discharge triage workflow

Workflow for vaginal discharge visits with infection-risk framing, pregnancy checks, and escalation boundaries.

Medium-risk workflowLast reviewed September 4, 2026

AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.

Scope

Use for

Outpatient initial management of vaginal discharge symptoms in stable patients.

Not for

Severe pelvic infection, hemodynamic instability, or emergency obstetric concerns.
Inpatient gynecology or infectious-disease management pathways.

Take a confidential symptom and sexual history; assess odor, itch, dysuria, bleeding, pelvic pain, pregnancy possibility and prior treatment.
Distinguish vaginitis from cervicitis, PID, physiologic discharge and irritant causes; appearance alone cannot reliably identify the organism.

Treat these as urgent. Escalate early if concern persists or follow-up is unreliable.

Emergency assessment for instability, severe pelvic pain, peritoneal signs or pregnancy with pain/bleeding suggesting ectopic pregnancy.
Suspected PID with pregnancy, severe illness, possible abscess, inability to tolerate oral treatment or unreliable follow-up needs urgent hospital assessment.

Test for pregnancy when relevant. Obtain vaginal testing for BV, Candida and trichomoniasis as indicated; use NAAT for chlamydia/gonorrhea when cervicitis or STI risk is present and for trichomoniasis where available.
Treat the identified or strongly suspected cause using pregnancy-appropriate guidance. Do not give the same empiric drug for every discharge presentation.
Symptomatic BV can be treated with oral metronidazole, vaginal metronidazole gel or vaginal clindamycin; choose a regimen from the BCCDC guide after contraindication and pregnancy checks.
Uncomplicated candidiasis can receive a vaginal azole such as clotrimazole; oral fluconazole should be avoided in pregnancy. Pregnancy and recurrent or severe candidiasis need an individualized regimen.
Trichomoniasis needs oral metronidazole and partner treatment; intravaginal metronidazole gel is ineffective. Use the PHAC regimen appropriate to pregnancy status.
Suspected PID requires prompt empiric treatment without waiting for STI results; use the current PHAC PID regimen and specialist advice when needed.
Arrange partner evaluation/treatment and reporting according to the confirmed STI and local public health requirements.

Track pending results and tailor treatment. Reassess persistent or recurrent symptoms rather than repeating empiric courses blindly.
Reassess PID response within 2-3 days; absent improvement requires urgent reassessment and possible hospitalization.
Give return precautions for fever, worsening pelvic pain, bleeding or pregnancy-related symptoms.

Return precautions you can say as written:

“If symptoms get worse, new warning signs appear, or you cannot follow the plan from this visit, seek urgent care now.”

Point to the red flags above that apply to this patient.
Confirm follow-up timing and where to go after hours.
Attach a relevant handout to reinforce the plan.
Document disposition, rationale, unresolved uncertainty, and that precautions were understood.

Clinical owner: Family Medicine Editorial Team
Risk tier: Medium
Review cadence: Every 6 months
Last reviewed: September 4, 2026AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
Review status: Evidence current. Next review due March 4, 2027.